Back to Search Start Over

MR Imaging Features of Retinoblastoma: Association with Gene Expression Profiles.

Authors :
Jansen RW
de Jong MC
Kooi IE
Sirin S
Göricke S
Brisse HJ
Maeder P
Galluzzi P
van der Valk P
Cloos J
Eekhout I
Castelijns JA
Moll AC
Dorsman JC
de Graaf P
Source :
Radiology [Radiology] 2018 Aug; Vol. 288 (2), pp. 506-515. Date of Electronic Publication: 2018 May 01.
Publication Year :
2018

Abstract

Purpose To identify associations between magnetic resonance (MR) imaging features and gene expression in retinoblastoma. Materials and Methods A retinoblastoma MR imaging atlas was validated by using anonymized MR images from referral centers in Essen, Germany, and Paris, France. Images were from 39 patients with retinoblastoma (16 male and 18 female patients [the sex in five patients was unknown]; age range, 5-90 months; inclusion criterion: pretreatment MR imaging). This atlas was used to compare MR imaging features with genome-wide messenger RNA (mRNA) expression data from 60 consecutive patients obtained from 1995 to 2012 (35 male patients [58%]; age range, 2-69 months; inclusion criteria: pretreatment MR imaging, genome-wide mRNA expression data available). Imaging pathway associations were analyzed by means of gene enrichment. In addition, imaging features were compared with a predefined gene expression signature of photoreceptorness. Statistical analysis was performed with generalized linear modeling of radiology traits on normalized log2-transformed expression values. P values were corrected for multiple hypothesis testing. Results Radiogenomic analysis revealed 1336 differentially expressed genes for qualitative imaging features (threshold P = .05 after multiple hypothesis correction). Loss of photoreceptorness gene expression correlated with advanced stage imaging features, including multiple lesions (P = .03) and greater eye size (P < .001). The number of lesions on MR images was associated with expression of MYCN (P = .04). A newly defined radiophenotype of diffuse-growing, plaque-shaped, multifocal tumors displayed overexpression of SERTAD3 (P = .003, P = .049, and P = .06, respectively), a protein that stimulates cell growth by activating the E2F network. Conclusion Radiogenomic biomarkers can potentially help predict molecular features, such as photoreceptorness loss, that indicate tumor progression. Results imply a possible role for radiogenomics in future staging and treatment decision making in retinoblastoma.<br /> (© RSNA, 2018 Online supplemental material is available for this article.)

Details

Language :
English
ISSN :
1527-1315
Volume :
288
Issue :
2
Database :
MEDLINE
Journal :
Radiology
Publication Type :
Academic Journal
Accession number :
29714679
Full Text :
https://doi.org/10.1148/radiol.2018172000